No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Imunon Announces Imnn-001 Abstract Accepted for Oral Presentation at 2025 Asco Annual Meeting
IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting
Imunon to Offer Up to 10M Shrs and 10M Warrants
Imunon Price Target Maintained With a $14.00/Share by HC Wainwright & Co.
Imunon Receives Buy Rating for Strategic Focus and Cost-Effective OVATION 3 Trial
FDA Aligns With Imunon's Phase III Trial Protocol for Ovarian Cancer Treatment